Join the club for FREE to access the whole archive and other member benefits.

Sanja Tomovska

CEO Quant Biomarkers and Managing Partner Deep Knowledge Group

More than a decade of work as strategic development head for several large Swiss and international pharmaceutical corporations (Novartis, Abbott Life Sciences).

Dr. Tomovska has a vast amount of experience across pharmaceutical portfolio stages and business delivery: strategy, lifecycle, venture development, R&D, M&A, clinical, marketing, and change management. She holds a PhD in molecular biology from the University of Basel, Switzerland in Biomarkers in Cancer Diagnostics and has a business education from INSEAD and Columbia Business School. 

Visit website: https://www.quant-biomarkers.com/#team

 sanjatomovska

See also: Company Quant Biomarkers - Development and application of human biomarker panels and biological age metrics

Details last updated 14-Dec-2021

Sanja Tomovska News

Quant Biomarkers established to develop sophisticated analytical products

Quant Biomarkers - 10-Dec-2021

DKG subsidiary to introduce biomarker-driven Longevity risk mitigation and intervention support

Read more...